Fundraising FoxFar East High Technology Fund
Government fundSeed–Growth
Find your way into Far East High Technology Fund
Sign up to see every warm intro you have to Far East High Technology Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Far East High Technology Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Frequently asked questions
- What stage does Far East High Technology Fund invest at?
- Far East High Technology Fund invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Far East High Technology Fund focus on?
- Far East High Technology Fund focuses on Sector Agnostic.
Similar investors
Mainstreet is a Seoul-based investment group operating across private equity and venture capital through its Mainstreet Investment and Mainstreet Ventures arms, backing entrepreneurs and companies from seed to pre-IPO.
HiJoJo Partners is a Japanese financial services firm that provides individual and institutional investors access to pre-IPO and late-stage private company investments, operating funds and an online platform (HiJoJo.com) alongside a private market solution for institutions and startups.
World Innovation Lab (WiL) is a US- and Japan-based fund backed by major global corporations and government entities in Japan and Asia, investing in growth-stage companies and serving as a bridge between startups and corporations as they expand globally.
O.G. Venture Partners is a multi-stage venture capital firm funded by a single limited partner, Ofer Global, that invests in founders building transformative companies.
MedVenture Partners is a Japanese venture capital firm specializing in medical device startups, supporting portfolio companies from clinical needs through commercialization and exit.